M

Magenta Therapeutics Inc
F:3MT

Watchlist Manager
Magenta Therapeutics Inc
F:3MT
Watchlist
Price: 11.136 EUR 0.29%
Market Cap: 368.6m EUR

Operating Margin
Magenta Therapeutics Inc

0%
Current
0%
Average
-4.2%
Industry

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
0%
=
Operating Profit
-83m
/
Revenue
0

Operating Margin Across Competitors

No Stocks Found

Magenta Therapeutics Inc
Glance View

Market Cap
368.6m EUR
Industry
Biotechnology

Magenta Therapeutics, Inc. is a clinical-stage biotechnology company, which engages in the development of novel medicines for bone marrow transplants. The company is headquartered in Cambridge, Massachusetts and currently employs 75 full-time employees. The company went IPO on 2018-06-21. The firm is developing medicines designed to bring the curative power of stem cell transplants to more patients with blood cancers, genetic diseases and autoimmune diseases. Its drug development pipeline includes multiple product candidates designed to improve stem cell transplants. Its lead clinical program is designed to mobilize and collect sufficient functional stem cells for use in stem cell transplantation, a process known as mobilization. The company is also developing product candidates that are designed to deplete targeted cells in the bone marrow to make space for the bone marrow to receive newly transplanted stem cells, a process known as conditioning. The firm's pipeline of stem cell transplant product candidates consists of MGTA-145, MGTA-117, C300, C100, G100, MGTA-456 and E478. The company is developing product candidates to be used individually or, in some cases, in combination with each other.

3MT Intrinsic Value
Not Available
What is Operating Margin?

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
0%
=
Operating Profit
-83m
/
Revenue
0
What is the Operating Margin of Magenta Therapeutics Inc?

Based on Magenta Therapeutics Inc's most recent financial statements, the company has Operating Margin of 0%.

Back to Top